People on the Move
GSK appoints RBS chairman, AstraZeneca knight joins R&D charity
The Chairman who steered the Royal Bank of Scotland Group (RBS) after its financial crisis losses will join GSK’s Board as a Non-Executive Director and Deputy Chairman.
Sir Philip Hampton will eventually succeed former Vodafone chief Sir Christopher Gent as Non-Executive Chairman in 2015 when he is released from other commitments. His total salary will amount to £700,000 (€896,000) per year.
GSK’s nominations committee, led by Sir Deryck Maughan, has been searching for a replacement Chair for two years, since before news of the company’s corruption scandal in China. Last week the company accepted a Rmb3bn (€385m) fine for bribery by sales staff, and five managers received suspended prison sentences.
Before RBS, Hampton chaired J Sainsbury and was Group Finance Director at Lloyds TSB Group, BT Group, BG Group, British Gas and British Steel.
(Picture credit: RBS)
